"Response and Survival Benefit with Chemoimmunotherapy in Epstein-Barr " by Brady E Beltran, Pilar Quiñones et al.
 

Response and Survival Benefit with Chemoimmunotherapy in Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma.

Document Type

Journal Article

Publication Date

6-22-2017

Journal

Hematological Oncology

DOI

10.1002/hon.2449

Peer Reviewed

1

Find in your library

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 24
  • Usage
    • Abstract Views: 16
  • Captures
    • Readers: 32
see details

Share

COinS